Follow
Timo ten Hagen
Timo ten Hagen
assoc Professor Erasmus MC, Experimental Oncology, head Nanomedicine Innovation Center Erasmus (NICE
Verified email at erasmusmc.nl - Homepage
Title
Cited by
Cited by
Year
TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility
R van Horssen, TLM Ten Hagen, AMM Eggermont
The oncologist 11 (4), 397-408, 2006
10152006
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors
AA Manzoor, LH Lindner, CD Landon, JY Park, AJ Simnick, MR Dreher, ...
Cancer research 72 (21), 5566-5575, 2012
4852012
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
RM Schiffelers, GA Koning, TLM ten Hagen, MHAM Fens, AJ Schraa, ...
Journal of Controlled Release 91 (1-2), 115-122, 2003
4282003
Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition
PM Krawczyk, B Eppink, J Essers, J Stap, H Rodermond, H Odijk, ...
Proceedings of the National Academy of Sciences 108 (24), 9851-9856, 2011
3782011
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
A Hollestelle, JHA Nagel, M Smid, S Lam, F Elstrodt, M Wasielewski, ...
Breast cancer research and treatment 121, 53-64, 2010
3422010
Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors
GA Koning, AMM Eggermont, LH Lindner, TLM ten Hagen
Pharmaceutical research 27, 1750-1754, 2010
3182010
Current uses of isolated limb perfusion in the clinic and a model system for new strategies
AMM Eggermont, JHW de Wilt, TLM ten Hagen
The lancet oncology 4 (7), 429-437, 2003
3152003
Cell membrane modulation as adjuvant in cancer therapy
S Zalba, TLM Ten Hagen
Cancer treatment reviews 52, 48-57, 2017
3062017
Macrophages eliminate circulating tumor cells after monoclonal antibody therapy
N Gül, L Babes, K Siegmund, R Korthouwer, M Bögels, R Braster, ...
The Journal of clinical investigation 124 (2), 812-823, 2014
2942014
Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
JHW De Wilt, TLM ten Hagen, G De Boeck, ST Van Tiel, EA De Bruijn, ...
British journal of cancer 82 (5), 1000-1003, 2000
2582000
In vivo micro particle image velocimetry measurements of blood-plasma in the embryonic avian heart
P Vennemann, KT Kiger, R Lindken, BCW Groenendijk, ...
Journal of biomechanics 39 (7), 1191-1200, 2006
2552006
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia
L Li, TLM ten Hagen, D Schipper, TM Wijnberg, GC van Rhoon, ...
Journal of Controlled Release 143 (2), 274-279, 2010
2482010
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy
L Li, TLM ten Hagen, M Hossann, R Süss, GC van Rhoon, ...
Journal of Controlled Release 168 (2), 142-150, 2013
2442013
Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate–containing RGD peptide liposomes inhibits experimental arthritis
GA Koning, RM Schiffelers, MHM Wauben, RJ Kok, E Mastrobattista, ...
Arthritis & Rheumatism 54 (4), 1198-1208, 2006
2162006
Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia
L Li, TLM ten Hagen, M Bolkestein, A Gasselhuber, J Yatvin, ...
Journal of Controlled Release 167 (2), 130-137, 2013
2062013
TNF-α augments intratumoural concentrations of doxorubicin in TNF-α-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects
AH van der Veen, JHW de Wilt, AMM Eggermont, ST van Tiel, ...
British journal of cancer 82 (4), 973-980, 2000
1992000
Tumor necrosis factor α mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response
ALB Seynhaeve, S Hoving, D Schipper, CE Vermeulen, ...
Cancer research 67 (19), 9455-9462, 2007
1872007
Role of CLASP2 in microtubule stabilization and the regulation of persistent motility
K Drabek, M van Ham, T Stepanova, K Draegestein, R van Horssen, ...
Current Biology 16 (22), 2259-2264, 2006
1872006
Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging
ALB Seynhaeve, BM Dicheva, S Hoving, GA Koning, TLM Ten Hagen
Journal of controlled release 172 (1), 330-340, 2013
1672013
Hyperthermia and smart drug delivery systems for solid tumor therapy
ALB Seynhaeve, M Amin, D Haemmerich, GC Van Rhoon, ...
Advanced Drug Delivery Reviews 163, 125-144, 2020
1632020
The system can't perform the operation now. Try again later.
Articles 1–20